Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy

Blood Cancer Journal

Volumn 2, Issue 5, 2012, Pages

  Kamdje, A H Nwabo ^a   Bassi, G ^a   Pacelli, L ^a   Malpeli, G ^b   Amati, E ^a   Nichele, I ^a   Pizzolo, G ^a   Krampera, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Chronic lymphocytic leukemia; CLL; Drug resistance; hBM MSCs; Human bone marrow mesenchymal stromal cells; Notch signaling

Indexed keywords

ANTIBODY; BENDAMUSTINE; CYCLOPHOSPHAMIDE; FLUDARABINE; GAMMA SECRETASE INHIBITOR; HYDROCORTISONE; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH4 RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL EXPANSION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; SIGNAL TRANSDUCTION;

EID: 84864026866     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2012.17     Document Type: Article

References (53)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804-815.
2. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 2006; 6: 107-116. (Pubitemid 43361586)
3. Nwabo Kamdje AH, Krampera M. Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment? Blood 2011; 118: 6506-6514.
4. Burger M, Hartmann T, Krome M, Rawluk J, Tamamura H, Fujii N et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 2005; 106: 1824-1830. (Pubitemid 41208600)
5. Balakrishnan K, Burger JA, Wierda WG, Gandhi V. AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. Blood 2009; 113: 149-153.
6. Bertrand FE, Spengemen JD, Shelton JG, McCubrey JA. Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in presence of stromal cell support. Leukemia 2005; 19: 98-102. (Pubitemid 40090083)
7. Long BW, Witte PL, Abraham GN, Gregory SA, Plate JM. Apoptosis and interleukin 7gene expression in chronic B-lymphocytic leukemia cells. Proc Natl Acad Sci USA 1995; 92: 1416-1420.
8. Lagneaux L, Delforge A, Bron D, De Bruyn C, Stryckmans P. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 1998; 91: 2387-2396.
9. Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1996; 92: 97-103. (Pubitemid 26018774)
10. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell Aquila M, Kipps TJ. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000; 96: 2655-2663.
11. Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 2005; 106: 1012-1020. (Pubitemid 41076448)
12. Deaglio S, Vaisitti T, Bergui L, Bonello L, Horenstein AL, Tamagnone L et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 2005; 105: 3042-3050.
13. Richardson SJ, Matthews C, Catherwood MA, Alexander HD, Carey BS, Farrugia J et al. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood 2006; 107: 3584-3592.
14. Pedersen IM, Kitada S, Leoni LM, Zapata JM, Karras JG, Tsukada N et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 2005; 100: 1795-1801. (Pubitemid 34925159)
15. Ruan J, Hyjek E, Kermani P, Christos PJ, Hooper AT, Coleman M et al. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin0s lymphoma. Clin Cancer Res 2006; 12: 5622-5631. (Pubitemid 44629588)
16. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147. (Pubitemid 29282067)
17. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and models of tissue repair - current views. Stem Cells 2007; 25: 2896-2902. (Pubitemid 350127874)
18. Burger JA, Gandhi V et al. The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions. Blood 2009; 114: 2560-2561.
19. Shain KH, Landowski TH, Dalton WS. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines. J Immunol 2002; 168: 2544-2553. (Pubitemid 34171863)
20. Vogler M, Butterworth M, Majid A, Walewska RJ, Sun XM, Dyer MJ et al. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood 2009; 113: 4403-4413.
21. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-776. (Pubitemid 29291335)
22. Radtke F, Fasnacht N, MacDonald HR. Notch signaling in the immune system. Immunity 2010; 32: 14-27.
23. Apelqvist A, Li H, Sommer L, Beatus P et al. Notch signaling controls pancreatic cell differentiation. Nature 1999; 400: 877-881. (Pubitemid 29406724)
24. Lobov IB, Renard RA, Papadopoulos N et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. PNAS 2007; 104: 3219-3224. (Pubitemid 46364140)
25. Loomes KM, Stevens SA, O'Brien ML et al. Dll3 and Notch1 genetic interactions model axial segmental and craniofacial malformations of human birth defects. Dev Dyn 2007; 236: 2943-2951. (Pubitemid 47613258)
26. Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F et al. TLR3 and TLR4 are expressed by human bone marrowderived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signalling. Stem Cells 2008; 26: 279-289.
27. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-848.
28. Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. PNAS 2007; 104: 3219-3224. (Pubitemid 46364140)
29. Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, Villamor N et al. Wholegenome sequencing identifies recurrent mutations in chronic lymphocytic leukemia. Nature 2011; 475: 101-105.
30. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of Notch1 mutational activation. J Exp Med 2011; 208: 1389-1401.
31. Zweidler-McKay PA, He Y, Xu L, Rodriguez CG, Karnell FG, Carpenter AC et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 2005; 106: 3898-3906. (Pubitemid 41739030)
32. Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, Malpeli G et al. Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage acute lymphoblastic leukemia cells in contact with human bone marrow-derived mesenchymal stromal cells. Blood 2011; 118: 380-389.
33. Rosati E, Sabatini R, Rampino G, Tabilio A, Di Ianni M, Fettucciari K et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009; 113: 856-865.
34. Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G et al. HB-EGF/HER-1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multi-lineage differentiation. Blood 2005; 106: 59-66. (Pubitemid 40967175)
35. Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W et al. Activation of Integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 2007; 67: 684-694. (Pubitemid 46192208)
36. Creagh EM, Sheehan D, Cotter TG. Heat shock proteins - modulators of apoptosis in tumour cells. Leukemia 2000; 14: 1161-1173. (Pubitemid 30445021)
37. Hubmann R, Schwarzmeier JD, Shehata M, Hilgarth M, Duechler M, Dettke M et al. Notch2 is involved in the over-expression of CD23 in B-cell chronic lymphocytic leukemia. Blood 2002; 99: 3742-3747. (Pubitemid 34534546)
38. Secchiero P, Melloni E, di Iasio MG, Tiribelli M, Rimondi E, Corallini F et al. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. Blood 2009; 113: 4300-4308.
39. Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood 1998; 91: 3379-3389. (Pubitemid 28193890)
40. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN et al. Induction of apoptosis cell death in chronic lymphocytic leukemia by 2-chloro-20-deoxyadenosine and 9-b-D-arabinosyl-2-fluoroadenine. Blood 1993; 81: 143-150. (Pubitemid 23013688)
41. Schwänen C, Hecker T, Hübinger G, Wölfle M, Rittgen W, Bergmann L et al. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia. Leukemia 2002; 16: 2096-2105. (Pubitemid 35203454)
42. Hoellenriegel J, Meadows SA, Sivina M, Wierda WG, Kantarjian H, Keating MJ et al. The phosphoinositide 30-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood 2011; 118: 133603-133612.
43. Fuente MT, Casanova B, Moyano JV, Mercedes GG, Laura S, José JM et al. Engagement of a4b1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. J Leuk Biol 2002; 71: 495-502.
44. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-372. (Pubitemid 43053565)
45. Hajdu M, Sebestyén A, Barna G, Reiniger L, Jánosi J, Sréter L et al. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells. Scand J Immunol 2007; 65: 271-275.
46. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T et al. Notch signaling controls pancreatic cell differentiation. Nature 1999; 400: 877-881. (Pubitemid 29406724)
47. Hallaert DYH, Jaspers A, van Noesel CJ, van Oers MHJ, Kater AP, Eldering E. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemo-resistant niches. Blood 2008; 112: 5141-5149.
48. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820-1828. (Pubitemid 23278773)
49. Kurtova AV, Balakrishnan K, Chen R, Ding W, Schnabl S, Quiroga MP et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009; 114: 4441-4450.
50. Fuente MT, Casanova B, Cantero E, Cerro MH, Garcia-Marco J, Silva A. Involvement of p53 in a4b1 integrin-mediated resistance of B-CLL cells to fludarabine. Biochem Biophys Res Communs 2003; 311: 708-712. (Pubitemid 37377714)
51. Damiano JS, Dalton WS. Integrin-Mediated Drug Resistance in Multiple Myeloma. Leuk Lymphoma 2000; 38: 71-81. (Pubitemid 30224324)
52. Sturm I, Bosanquet AG, Hermann S, Guner D, Dorken B, Daniel PT. Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy. Cell Death Differ 2003; 10: 477-484. (Pubitemid 36626360)
53. Wickremasinghe RG, Prentice AG, Steele AJ. p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. Leukemia 2011; 25: 1400-1407.